Therapeutic Advances in the Management of Smoldering Myeloma.

Khan, Rafiullah; Zahid, Umar; Kollu, Vidya; Jahan, Nusrat; Ali, McBride; Tricot, Guido; Anwer, Faiz

Khan, Rafiullah; Zahid, Umar; Kollu, Vidya; Jahan, Nusrat; Ali, McBride; Tricot, Guido; Anwer, Faiz.

Afiliación

Khan R; Division of Hematology & Oncology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH.
Zahid U; Department of Rheumatology, John Hopkins University Medical Center, Baltimore, MD.
Kollu V; Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, WI.
Jahan N; Division of Hematology and Oncology, Texas Tech University, Lubbock, TX.
Ali M; Department of Pharmacy, Banner Health University of Arizona, Tucson, AZ.
Tricot G; Division of Hematology and Oncology, Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City, IA; and.
Anwer F; Division of Hematology, Taussing Cancer Center, Oncology and Stem Cell Transplantation, Cleveland Clinic, OH.

Am J Ther ; 27(2): e194-e203, 2020.

Article en En | MEDLINE | ID: mdl-31842112

Asunto(s)

Antineoplásicos/uso terapéutico; Mieloma Múltiple Quiescente/tratamiento farmacológico; Manejo de la Enfermedad; Humanos; Proteínas de Mieloma/genética; Mieloma Múltiple Quiescente/genética; Análisis de Supervivencia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Quiescente / Antineoplásicos Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Am J Ther Asunto de la revista: TERAPEUTICA Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google